Cargando…

Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo

(Background) The coronavirus disease 2019 (COVID-19) that is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) carries high infectivity and mortality. Efficient intervention strategies are urgently needed. Avian immunoglobulin Y (IgY) showed efficacy against viral infection wher...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeh, Chia-Tsui, Lee, Chia-Ying, Ho, Yi-Jung, Chen, Sin-An, Chen, Liang-Yu, Liu, Ping-Cheng, Chin, Yuan-Fan, Chen, An-Yu, Hsieh, Po-Shiuan, Hung, Yi-Jen, Chen, Cheng-Cheung, Wang, Yu-Chie, Lee, Guan-Chiun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687769/ https://www.ncbi.nlm.nih.gov/pubmed/36359294 http://dx.doi.org/10.3390/biomedicines10112774

Ejemplares similares

Antibody detection of SARS-CoV spike and nucleocapsid protein
por: Chang, Mau-Sun, et al.
Publicado: (2004)

CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
por: Lien, Chia-En, et al.
Publicado: (2021)

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
por: Wu, Wan-Ling, et al.
Publicado: (2022)

Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking
por: Tien, Chih-Feng, et al.
Publicado: (2022)

Structural dynamic changes in the SARS-CoV and SARS-CoV-2 S spike assemblies upon ACE2 activation
por: Chen, Chengbo, et al.
Publicado: (2022)

Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats
por: Liu, Ran-Yi, et al.
Publicado: (2005)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
por: Zheng, Zhiqiang, et al.
Publicado: (2020)

Structure of SARS-CoV-2 spike protein
por: Zhang, Jun, et al.
Publicado: (2021)

SARS-CoV-2 spike S2-specific neutralizing antibodies
por: Li, Chia-Jung, et al.
Publicado: (2023)

DockCoV2: a drug database against SARS-CoV-2
por: Chen, Ting-Fu, et al.
Publicado: (2020)

High-Integrity Sequencing of Spike Gene for SARS-CoV-2 Variant Determination
por: Liao, Yu-Chieh, et al.
Publicado: (2022)

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV
por: Zhou, Huan, et al.
Publicado: (2021)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2
por: Chang, Young-Sheng, et al.
Publicado: (2022)

A case of transient existence of SARS-CoV-2 RNA in the respiratory tract with the absence of anti-SARS-CoV-2 antibody response
por: Lin, Yi-Chun, et al.
Publicado: (2020)

Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
por: Zhang, Xixi, et al.
Publicado: (2023)

Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
por: Ko, Shih-Han, et al.
Publicado: (2022)

Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2
por: Tanikawa, Takashi, et al.
Publicado: (2022)

Venetoclax Decreases the Expression of the Spike Protein through Amino Acids Q493 and S494 in SARS-CoV-2
por: Chen, Chih-Chieh, et al.
Publicado: (2022)

Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan
por: Cheng, Chien-Yu, et al.
Publicado: (2020)

Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
por: D’Arco, Annalisa, et al.
Publicado: (2023)

O-Glycosylation Landscapes of SARS-CoV-2 Spike Proteins
por: Zhang, Yong, et al.
Publicado: (2021)

In-Silico Selection of Aptamer Targeting SARS-CoV-2 Spike Protein
por: Lin, Yu-Chao, et al.
Publicado: (2022)

Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV
por: Shekhawat, Uma, et al.
Publicado: (2022)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

Surface vimentin is critical for the cell entry of SARS-CoV
por: Yu, Yvonne Ting-Chun, et al.
Publicado: (2016)

Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
por: Hatmal, Ma’mon M., et al.
Publicado: (2020)

hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics
por: Chen, Chengbo, et al.
Publicado: (2023)

Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2021)

Comparative susceptibility of SARS-CoV-2, SARS-CoV, and MERS-CoV across mammals
por: Li, Meng, et al.
Publicado: (2023)

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
por: Cheng, Fang-Ju, et al.
Publicado: (2023)

Imaging findings in coronavirus infections: SARS-CoV, MERS-CoV, and SARS-CoV-2
por: Franquet, Tomas, et al.
Publicado: (2020)

The Spike of SARS-CoV-2: Uniqueness and Applications
por: Kumavath, Ranjith, et al.
Publicado: (2021)

Amyloidogenesis of SARS-CoV-2 Spike Protein
por: Nyström, Sofie, et al.
Publicado: (2022)

SARS-CoV-2 and the spike protein in endotheliopathy
por: Perico, Luca, et al.
Publicado: (2023)

Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection
por: Lin, Jhe-Jhih, et al.
Publicado: (2022)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
por: Yu, Sicong, et al.
Publicado: (2021)

SARS-CoV-2 variants – Evolution, spike protein, and vaccines
por: Chen, Kai-Wei K., et al.
Publicado: (2022)

Assessment of adjuvantation strategy of lipid squalene nanoparticles for enhancing the immunogenicity of a SARS-CoV-2 spike subunit protein against COVID-19
por: Ho, Hui-Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e75jvsiv251m7a5002qrviu2i6